PUREGAM

Pharmaceutical preparations derived from plasma and/or recombinant DNA technology for the prevention and/or treatment of blood disorders; immunoglobulins; normal human immunoglobulin for the treatment of immune deficiencies, none of the aforesaid goods being used in relation to preparations for gynaecology